Literature DB >> 3828560

Physiological pharmacokinetics.

K B Bischoff.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3828560     DOI： 10.1007/bf02459684

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN： 0092-8240            Impact factor:   1.758


× No keyword cloud information.
  15 in total

1.  Quantitative Relations in the Physiological Constitutions of Mammals.

Authors:  E F Adolph
Journal:  Science       Date:  1949-06-10       Impact factor: 47.728

Review 2.  A review of the applications of physiologically based pharmacokinetic modeling.

Authors:  K J Himmelstein; R J Lutz
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 3.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

5.  In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.

Authors:  R L Dedrick; D D Forrester; D H Ho
Journal:  Biochem Pharmacol       Date:  1972-01       Impact factor: 5.858

6.  Animal scale-up.

Authors:  R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

7.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

8.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

9.  Species similarities in pharmacokinetics.

Authors:  R L Dedrick; K B Bischoff
Journal:  Fed Proc       Date:  1980-01

10.  Extrapolation of experimental data from animals to man.

Authors:  G N Krasovskii
Journal:  Environ Health Perspect       Date:  1976-02       Impact factor: 9.031
View more
  10 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

Review 5.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

6.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

7.  Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.

Authors:  Matthew D Thompson; Daniel A Beard
Journal:  J Pharm Sci       Date:  2011-10-03       Impact factor: 3.534

8.  Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.

Authors:  Peter Veng-Pedersen; Kevin J Freise; Robert L Schmidt; John A Widness
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

9.  Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.

Authors:  R J MacFadyen; K R Lees; J D Gemmill; W S Hillis; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

10.  Physiologically Based Pharmacokinetic Modeling of Fluorescently Labeled Block Copolymer Nanoparticles for Controlled Drug Delivery in Leukemia Therapy.

Authors:  M J Gilkey; V Krishnan; L Scheetz; X Jia; A K Rajasekaran; P S Dhurjati
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.